Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and l-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass
- 29 February 1996
- journal article
- research article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 111 (2), 451-459
- https://doi.org/10.1016/s0022-5223(96)70456-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Changes in neutrophil CD11b/CD18 andl-selectin expression and release of interleukin 8 and elastase in paediatric cardiopulmonary bypassInflammation Research, 1993
- Systemic inflammation during paediatric cardiopulmonary bypass: changes in neutrophil adhesive propertiesPerfusion, 1993
- Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigrationImmunology Today, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8Science, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Bubble and Membrane Oxygenators—Comparison of Postoperative Organ Dysfunction with Special Reference to Inflammatory ActivityScandinavian Journal of Thoracic and Cardiovascular Surgery, 1990
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- Elastase-α1-proteinase inhibitor in early diagnosis of neonatal septicemiaThe Journal of Pediatrics, 1986
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.JCI Insight, 1978